Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02909660
Other study ID # 30006114
Secondary ID
Status Terminated
Phase N/A
First received September 14, 2016
Last updated December 10, 2017
Start date September 2016
Est. completion date November 2017

Study information

Verified date December 2017
Source Concordia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the efficacy and acceptability of two cognitive-behavioural interventions for reassurance seeking behaviour in obsessive-compulsive disorder (OCD), a family accommodation reduction protocol vs. a novel support-seeking protocol. Half of participants will be randomly assigned to participate in the support-seeking intervention, whereas the other half will participate in the family accommodation reduction intervention.


Description:

An existing family accommodation reduction intervention to reduce reassurance seeking behaviour in OCD (which represents treatment as usual, or TAU) is being compared to a novel support-seeking intervention to determine which is more efficacious and acceptable to participants.

The TAU protocol asks participants to make an agreement with their significant others to withhold reassurance when it is sought. It is believed that this behaviourally-based intervention encourages extinction of reassurance seeking over time by eliminating reinforcement of the behaviour by significant others.

The support-seeking intervention asks participants to move towards adaptively seeking support from a significant other to manage anxiety or distress rather than seeking reassurance. Significant others are taught to provide support rather than reassurance. It is believed that support-seeking may reduce reassurance seeking behaviour because it helps participants manage the anxiety or distress that underlies the requests for reassurance without interfering with disconfirmatory learning.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date November 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of OCD

- Engaging in reassurance seeking more than once a day about the same thing

- Willingness to allow the experimenter to contact a significant other from whom the participant seeks reassurance regularly

- Ability to read, write, and communicate in English

Exclusion Criteria:

- Current suicidal ideation/intent

- Current substance abuse

- Psychosis

- Diagnosis of bipolar disorder (I or II)

- If participants are on medication they must be on a stable dose (i.e., have maintained a consistent dose for at least three months) and agree not to change their medication regimen for the duration of the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive-behavioural therapy
Empirically-supported psychological intervention for various mental health concerns including obsessive-compulsive disorder (OCD). Includes components to foster cognitive (i.e., thinking) and behavioural changes.

Locations

Country Name City State
Canada Concordia University Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Concordia University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported reassurance seeking behaviour Number of times participants self-report seeking reassurance per day 5 weeks (baseline through 3 week follow-up)
Primary Self-reported support-seeking behaviour Number of times participants in the support-seeking condition self-report seeking reassurance per day 4 weeks (condition assignment through 3 week follow-up)
Primary Self-reported anxiety Level of anxiety on average per day, self-rated from 0-100 5 weeks (baseline monitoring through 3 week follow-up)
Primary One-week follow-up: Treatment Acceptability and Adherence Scale (TAAS; Milosevic, Levy, Alcolado, & Radomsky, 2015) Validated questionnaire assessing how acceptable participants find an intervention as well as ease of adherence. One-week follow-up
Primary One-week follow-up: Endorsement and Discomfort Scales (EDS; Tarrier, Liversidge, & Gregg, 2006) Validated questionnaire assessing acceptability of and discomfort caused by an intervention. One-week follow-up
Primary Three-week follow-up: Treatment Acceptability and Adherence Scale (TAAS; Milosevic, Levy, Alcolado, & Radomsky, 2015) Validated questionnaire assessing how acceptable participants find an intervention as well as ease of adherence. Three-week follow-up
Primary Three-week follow-up: Endorsement and Discomfort Scales (EDS; Tarrier, Liversidge, & Gregg, 2006) Validated questionnaire assessing acceptability of and discomfort caused by an intervention. Three-week follow-up
Secondary Change in self-reported reassurance-seeking Pre-post assessment of change in the number of times per day that participants self-report reassurance seeking behaviour from the baseline monitoring week to the follow-up assessments. Baseline to one-week follow-up and baseline to three-week follow-up
Secondary Change in anxiety Pre-post assessment of change in participants' self-reported anxiety ratings, as rated from 0-100 Baseline (monitoring week 1) to end of reassurance provision week (monitoring week 2)
See also
  Status Clinical Trial Phase
Recruiting NCT04934007 - Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder N/A
Recruiting NCT04071990 - Family Involvement in CBGT of OCD: a Randomized Controlled Trial N/A
Completed NCT02541968 - Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Recruiting NCT05391503 - Light Therapy for Obsessive-compulsive Disorder (OCD) N/A
Recruiting NCT04539951 - Pragmatic Trial of Obsessive-compulsive Disorder Phase 2
Completed NCT03416504 - Methods for Managing Intrusive Thoughts N/A
Not yet recruiting NCT06029738 - Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD N/A
Recruiting NCT02844049 - European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS N/A
Completed NCT02911324 - Cannabinoid Medication for Adults With OCD Phase 1/Phase 2
Completed NCT02217995 - Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients N/A
Terminated NCT02234011 - A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder Phase 2
Withdrawn NCT01953042 - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders N/A
Completed NCT02655926 - Deep Brain Stimulation for Severe Obsessive Compulsive Disorder N/A
Terminated NCT00758966 - Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Phase 2
Completed NCT00742664 - Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project Phase 1/Phase 2
Completed NCT04919785 - Deep Brain Stimulation in Severe Obsessive-compulsive Disorder N/A
Completed NCT00523718 - Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder Phase 2
Completed NCT00074815 - Treatment of Obsessive Compulsive Disorder in Children Phase 3
Recruiting NCT04106102 - Study of the Effectiveness of Transcranial Direct Current Stimulation on Obsessive Compulsive Disorder N/A